Related Experiment Video
Updated: Jun 26, 2025
12:52
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.8K
Influence of SLC40A1 on Cytokine Interactions and Immune Infiltration in Glioblastoma
Jiahao Jiang1,2, Riquan Duan1, Junle Zhu1
1Department of Neurosurgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Neuromolecular Medicine
|May 15, 2024
Summary
High Slc40a1 expression in glioblastoma (GBM) correlates with a better prognosis. Slc40a1 influences the tumor immune microenvironment via cytokine interactions, suggesting potential for immunotherapeutic strategies.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Slc40a1 (Solute Carrier Family 40 Member 1) functions are studied in cancer.
- Its specific role in primary glioblastoma (GBM) remains under-investigated.
Purpose of the Study:
- To investigate the role of Slc40a1 in glioblastoma.
- To explore the molecular mechanisms linking Slc40a1 expression to patient prognosis.
Main Methods:
- Bioinformatic analysis of TIMER and TCGA databases.
- Gene Ontology (GO), KEGG pathway, and Gene Set Enrichment Analysis (GSEA).
- Immune infiltration analysis, correlation studies, tissue microarray validation, and immunofluorescence.
Main Results:
- High Slc40a1 expression is associated with favorable prognosis in GBM patients.
- Slc40a1 modulates the tumor immune microenvironment, particularly through interactions with Ccl14 and Il18.
- Validation confirmed the correlation between high SLC40A1 protein levels and improved outcomes, alongside IL18 and CCL14 expression.
Conclusions:
- Slc40a1 plays a role in GBM pathogenesis by regulating the tumor immune microenvironment via Il18 and Ccl14.
- Targeting Slc40a1 presents potential for novel immunotherapeutic interventions and prognostic assessments in GBM.
